Inicio › Cáncer del colon y del recto › Pensilvania › Philadelphia
Ensayos clínicos de Cáncer del colon y del recto en Philadelphia, PA
44 estudios para Cáncer del colon y del recto buscan participantes en centros de Philadelphia y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
ReclutandoFase 1/2
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
ReclutandoFase 2
- Christiana Care Health System-Concord Health Center, Chadds Ford · A 23 mi de distancia
- Christiana Care Health System-Wilmington Hospital, Wilmington · A 25 mi de distancia
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Reading Hospital McGlinn Cancer Institute at Phoenixville, Phoenixville · A 22 mi de distancia
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
ReclutandoFase 1
- Exelixis Clinical Site #98, Philadelphia
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
ReclutandoFase 3
- Thomas Jefferson University, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- Alliance Cancer Specialists at Main Line, Penn Wynne · A 6 mi de distancia
A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors
ReclutandoFase 1
- GSK Investigational Site, Philadelphia
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
ReclutandoFase 1
- Research Site, Philadelphia
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
ReclutandoFase 3
- Thomas Jefferson University, Philadelphia
- Fox Chase Cancer Center, Philadelphia
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
ReclutandoFase 3
- Fox Chase Cancer Center, Philadelphia
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
ReclutandoFase 1
- University of Pennsylvania, Philadelphia
- Fox Chase Cancer Center, Philadelphia
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
ReclutandoFase 1/2
- Hospital of the University of Pennsylvania, Philadelphia
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
ReclutandoFase 3
- University of Pennsylvania, Philadelphia
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
ReclutandoFase 3
- Clinical Study Site, Philadelphia
- Clinical Study Site, Philadelphia
- Clinical Study Site, Philadelphia
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
ReclutandoFase 1
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
ReclutandoFase 2
- Thomas Jefferson University - Sidney Kimmel Comprehensive Cancer Center, Philadelphia
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
ReclutandoFase 1/2
- Children's Hospital of Philadelphia, Philadelphia
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients
ReclutandoEstudio observacional
- University of Pennsylvania, Philadelphia
FOG-001 in Locally Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- University of Pennsylvania, Perelman School of Medicine, Philadelphia
TCR1188-ABC Cells in KRAS-mutated Cancers
ReclutandoFase 1
- University of Pennsylvania, Philadelphia
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- University of Pennsylvania / Abramson Cancer Center, Philadelphia
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Research Organization, Philadelphia
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
ReclutandoFase 1
- Thomas Jefferson University, Philadelphia
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
ReclutandoFase 1/2
- University of Pennsylvania, Philadelphia
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
ReclutandoFase 1
- Jefferson University Hospitals, Philadelphia
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
ReclutandoFase 2
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
ReclutandoFase 2
- Abramson Cancer Center at the University of Pennsylvania /ID# 275407, Philadelphia
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
ReclutandoFase 4
- Jefferson Health, Philadelphia
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
ReclutandoFase 1
- Sidney Kimmel Cancer Center, Philadelphia
CT-95 in Advanced Cancers Associated With Mesothelin Expression
ReclutandoFase 1
- University of Pennsylvania, Philadelphia
- Context Investigational Site, Philadelphia
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
ReclutandoFase 2
- Alliance Cancer Specialists, Wynnewood · A 7 mi de distancia
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
ReclutandoFase 1/2
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
GUCY2C Prime-Boost Vaccination for Advanced Colorectal and Small Bowel Adenocarcinomas
ReclutandoFase 1
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
ReclutandoFase 1
- Sydney Kimmel Cancer Center, Philadelphia
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
ReclutandoFase 1/2
- Univ of Pennsylvania, Abramson Cancer Center, Philadelphia
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
ReclutandoFase 3Se aceptan voluntarios sanos
- Christiana Care Health System-Concord Health Center, Chadds Ford · A 23 mi de distancia
- Christiana Care Health System-Wilmington Hospital, Wilmington · A 25 mi de distancia
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
ReclutandoFase 1/2
- Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Philadelphia
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
ReclutandoFase 1/2
- University of Pennsylvania, Philadelphia
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- University of Pennsylvania, Philadelphia
A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy
ReclutandoFase 1/2
- University of Pennsylvania, Philadelphia
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
ReclutandoFase 4
- Albert Einstein Healthcare Network, Philadelphia
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
ReclutandoEstudio observacional
- Christiana Care Health System-Wilmington Hospital, Wilmington · A 25 mi de distancia
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
ReclutandoEstudio observacional
- Christiana Care Health System-Wilmington Hospital, Wilmington · A 25 mi de distancia
Collection of Samples USOPTIVAL Study
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- University of Pennsylvania, Philadelphia
Neuroprotective Potential of Cannabidiol (CBD) in Preventing Oxaliplatin (Ox)-Induced Neuropathy
ReclutandoFase 1 temprana
- Fox Chase Cancer Center, Philadelphia
Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer
ReclutandoFase 3
- Perelman Center for Advanced Medicine, Philadelphia
Más información sobre Cáncer del colon y del recto en MedlinePlus
Ensayos de Cáncer del colon y del recto en otras ciudades
- Houston, TX102 estudios
- New York City, NY78 estudios
- Nashville, TN69 estudios
- Boston, MA63 estudios
- Los Angeles, CA59 estudios
- Arlington, VA52 estudios
- St. Louis, MO50 estudios
- San Antonio, TX46 estudios
- Grand Rapids, MI40 estudios
- Baldwin Park, CA37 estudios
- Chicago, IL34 estudios
- Tampa, FL34 estudios
Otros estudios en Philadelphia
- Cáncer (todos los tipos)59 estudios
- Cáncer de seno56 estudios
- Cáncer de pulmón de células no pequeñas51 estudios
- Cáncer metastásico46 estudios
- Cáncer de próstata44 estudios
- Cáncer de ovario44 estudios
- Cáncer de pulmón36 estudios
- Leucemia mielógena aguda34 estudios
- Fallo cardíaco31 estudios
- Cáncer de endometrio28 estudios
- Depresión26 estudios
- Cáncer de páncreas26 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.